Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making

Background: Antiretroviral treatment (ART) has been associated with the development of certain cardiometabolic diseases (CMDs). The burden of CMDs amongst ART-experienced patients in sub-Saharan Africa was unknown. Objective: We quantified the burden of CMDs and identified the associated risk facto...

Full description

Bibliographic Details
Main Authors: Motlalepula Sebilo, Neo R.T. Ledibane, Simbarashe Takuva
Format: Article
Language:English
Published: AOSIS 2021-06-01
Series:Southern African Journal of HIV Medicine
Subjects:
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/1246
_version_ 1818538355183321088
author Motlalepula Sebilo
Neo R.T. Ledibane
Simbarashe Takuva
author_facet Motlalepula Sebilo
Neo R.T. Ledibane
Simbarashe Takuva
author_sort Motlalepula Sebilo
collection DOAJ
description Background: Antiretroviral treatment (ART) has been associated with the development of certain cardiometabolic diseases (CMDs). The burden of CMDs amongst ART-experienced patients in sub-Saharan Africa was unknown. Objective: We quantified the burden of CMDs and identified the associated risk factors in a large treatment cohort on ART at a high-volume facility in Lesotho. Methods: In this retrospective cohort study, we extracted data from the daily dispensing electronic system and routine clinical records of 785 adults on ART between 2011 and 2015 in Maseru, Lesotho. CMD was defined as a diagnosis of hypertension, diabetes mellitus or dyslipidaemia (singly or collectively). Descriptive statistics were used to describe the disease burden; Kaplan–Meier curves and cause-specific Cox proportional hazards models were fitted to examine the impact of the ART regimen and identify the risk factors associated with the occurrence of CMD. Results: Of the 785 participants, 473 (60%) were women. The median age of the group was 42 years, interquartile range (IQR), 36–51 years. The overall incidence of CMD was 5.6 (95% confidence interval [CI] = 4.4–7.1) per 100 person-months of follow-up. The median time to onset of CMD was 16.6 months (IQR = 7.4–23.4). ART was not associated with the occurrence of CMD (cause-specific hazard ratio [CHR] = 1.55; 95% CI = 0.14–16.85; P = 0.72). Higher body mass index (BMI) was associated with the occurrence of diabetes mellitus (CHR = 1.19; 95% CI = 1.14–1.38; P = 0.026). Conclusion: The incidence of CMD in this relatively young patient population is low yet noteworthy. We recommend that patients living with HIV and AIDS should be routinely screened for CMD. Higher BMI is generally associated with the occurrence of CMD.
first_indexed 2024-12-11T21:27:56Z
format Article
id doaj.art-a0c0519ae4ba4de0a090362656f3580d
institution Directory Open Access Journal
issn 1608-9693
2078-6751
language English
last_indexed 2024-12-11T21:27:56Z
publishDate 2021-06-01
publisher AOSIS
record_format Article
series Southern African Journal of HIV Medicine
spelling doaj.art-a0c0519ae4ba4de0a090362656f3580d2022-12-22T00:50:17ZengAOSISSouthern African Journal of HIV Medicine1608-96932078-67512021-06-01221e1e710.4102/sajhivmed.v22i1.1246754Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-makingMotlalepula Sebilo0Neo R.T. Ledibane1Simbarashe Takuva2School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; and, Elizabeth Glaser Pediatric AIDS Foundation, Maseru, LesothoSchool of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, PretoriaSchool of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; and, Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, JohannesburgBackground: Antiretroviral treatment (ART) has been associated with the development of certain cardiometabolic diseases (CMDs). The burden of CMDs amongst ART-experienced patients in sub-Saharan Africa was unknown. Objective: We quantified the burden of CMDs and identified the associated risk factors in a large treatment cohort on ART at a high-volume facility in Lesotho. Methods: In this retrospective cohort study, we extracted data from the daily dispensing electronic system and routine clinical records of 785 adults on ART between 2011 and 2015 in Maseru, Lesotho. CMD was defined as a diagnosis of hypertension, diabetes mellitus or dyslipidaemia (singly or collectively). Descriptive statistics were used to describe the disease burden; Kaplan–Meier curves and cause-specific Cox proportional hazards models were fitted to examine the impact of the ART regimen and identify the risk factors associated with the occurrence of CMD. Results: Of the 785 participants, 473 (60%) were women. The median age of the group was 42 years, interquartile range (IQR), 36–51 years. The overall incidence of CMD was 5.6 (95% confidence interval [CI] = 4.4–7.1) per 100 person-months of follow-up. The median time to onset of CMD was 16.6 months (IQR = 7.4–23.4). ART was not associated with the occurrence of CMD (cause-specific hazard ratio [CHR] = 1.55; 95% CI = 0.14–16.85; P = 0.72). Higher body mass index (BMI) was associated with the occurrence of diabetes mellitus (CHR = 1.19; 95% CI = 1.14–1.38; P = 0.026). Conclusion: The incidence of CMD in this relatively young patient population is low yet noteworthy. We recommend that patients living with HIV and AIDS should be routinely screened for CMD. Higher BMI is generally associated with the occurrence of CMD.https://sajhivmed.org.za/index.php/hivmed/article/view/1246aidsantiretroviral treatmentcardiometabolic diseasehivincidence ratelesotho
spellingShingle Motlalepula Sebilo
Neo R.T. Ledibane
Simbarashe Takuva
Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making
Southern African Journal of HIV Medicine
aids
antiretroviral treatment
cardiometabolic disease
hiv
incidence rate
lesotho
title Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making
title_full Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making
title_fullStr Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making
title_full_unstemmed Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making
title_short Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making
title_sort incidence of cardiometabolic diseases in a lesotho hiv cohort evidence for policy decision making
topic aids
antiretroviral treatment
cardiometabolic disease
hiv
incidence rate
lesotho
url https://sajhivmed.org.za/index.php/hivmed/article/view/1246
work_keys_str_mv AT motlalepulasebilo incidenceofcardiometabolicdiseasesinalesothohivcohortevidenceforpolicydecisionmaking
AT neortledibane incidenceofcardiometabolicdiseasesinalesothohivcohortevidenceforpolicydecisionmaking
AT simbarashetakuva incidenceofcardiometabolicdiseasesinalesothohivcohortevidenceforpolicydecisionmaking